# China NMPA Drug Inspection - Guangdong Luofu Mountain Baihe Pharmaceutical Factory - Compound Danshen Tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangdong-luofu-mountain-baihe-pharmaceutical-factory/368292da-61a0-4fae-ae2f-13a653f0aaac/
Source feed: China

> China NMPA drug inspection for Guangdong Luofu Mountain Baihe Pharmaceutical Factory published March 25, 2020. Drug: Compound Danshen Tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 1, 2020)
- Company Name: Guangdong Luofu Mountain Baihe Pharmaceutical Factory
- Publication Date: 2020-03-25
- Drug Name: Compound Danshen Tablets
- Inspection Finding: [Content Determination] Tanshinone IIA
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/guangdong-luofu-mountain-baihe-pharmaceutical-factory/444f4d03-8901-488e-a367-5b8604a93ba3/